Posted by alexyap > 2014-10-17 21:42 | Report Abuse

hi, just screening thru this company. In their annual report, the liabilities were quite high. Not a good analysis on financial reports. Anyone mind explaining the financial condition of this company? Thanks. Would like to buy and keep some for long term.

Posted by reachabbler > 2014-10-21 17:00 | Report Abuse

DKSH extends relationship with Roche across Asia

15.10.2014 | DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Roche to extend the duration of its decades-long partnership across Asian markets and expand it geographically.

Bangkok, Thailand, October 15, 2014 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, will continue to provide Market Expansion Services for Roche’s full pharmaceutical product portfolio in Cambodia, Hong Kong, Laos, Malaysia, Myanmar, Singapore, Thailand and Vietnam.

DKSH is managing Roche’s entire supply chain operations for pharmaceutical products and distribution to hospitals, clinics and pharmacies in the region. It is the first time that DKSH and Roche work together in Singapore. In the other Asian markets, the agreement is a long-term extension of existing relationships that date back to as long as the 1940s.

“The extension of our agreement into new markets provides opportunities for Roche. DKSH is a reliable and professional partner that helps us grow our business across Asia, so that we can focus on our core business,” said Philippe Meyer, General Manager, Roche Thailand Limited.

“DKSH and Roche enjoy a long and successful collaboration. We are committed to utilize our in-depth healthcare expertise and network of unique scope and depth for growing Roche’s business in new and existing markets,” said Thomas Delemazure, Regional Business Development Director, DKSH Healthcare.

The agreement will further strengthen DKSH’s market position in the region while contributing incrementally to the Group’s overall profitability over time.

About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics and a frontrunner in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2013 the Roche Group employed over 85,000 people worldwide, invested 8.7 billion Swiss francs in R&D and posted sales of 46.8 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

Posted by reachabbler > 2014-10-21 17:01 | Report Abuse

DKSH and Aspen expand reach in Malaysia

16.10.2014 | DKSH, the leading Market Expansion Services provider with a focus on Asia, signed an agreement with Aspen Malaysia, to drive sales of consumer health brands Dequadin and Cortal across Malaysia.

Kuala Lumpur, Malaysia, October 16, 2014 – DKSH Business Unit Consumer Goods, Asia’s leading Market Expansion Services specialist for Fast Moving Consumer Goods, has been appointed by Aspen Malaysia to provide marketing, sales and distribution services for its consumer health brands Dequadin and Cortal. The agreement includes retail channels in West and East Malaysia as well as Brunei.

Locally produced, Dequadin is one of Malaysia’s most popular throat lozenges and pastilles brands. Cortal is Aspen’s brand name for paracetamol. The company sees opportunities for growth in a wider range of retail channels including leading pharmacies, supermarkets, convenience stores, petrol marts and mini-markets nationwide.

“We selected DKSH for its extensive capillary distribution and its experience in driving sales for mature products. This partnership provides new opportunities for us to grow our business in the important Malaysian market. Outsourcing some of our activities to DKSH allows us to focus on our core competencies,” said Andrew Ooi, Country Manager, Aspen Malaysia.

“Aspen has built up a strong brand portfolio in the Malaysian market. We will leverage our network of unique scope and depth and marketing capabilities to further increase visibility and availability of the Dequadin and Cortal brands,” commented Lian Teng Hai, Executive Director, Business Unit Consumer Goods, DKSH Malaysia.

DKSH also provides Market Expansion Services for Dequadin in the pharmacy channel in Thailand. The new partnership will further strengthen DKSH’s market position in Malaysia while contributing incrementally to the Group’s overall profitability over time.

About Aspen Medical Products Malaysia Sdn Bhd
Aspen Medical Products Malaysia Sdn Bhd is part of South Africa’s Aspen Group. Aspen Group is a leading generics supplier and manufacturer in the southern hemisphere and is Africa's largest pharmaceutical manufacturer. It is also ranked as Australia's number one generic pharmaceutical company. Aspen has 17 manufacturing facilities at 12 pharmaceutical manufacturing sites on six continents and approximately 6,000 employees.

Posted by reachabbler > 2014-11-10 19:07 | Report Abuse

LTAT http://www.bursamalaysia.com/market/listed-companies/company-announcements/1789921

Posted by Flintstones > 2014-11-15 13:08 | Report Abuse

DKSH is trading around 15++ PE as of now. If you think DKSH is worth 30X PE, then RM 6.50 is a good buy

Posted by Marvyn Choong > 2014-11-20 10:05 | Report Abuse

At RM6.50, PE only 13. Why Flintstones said PE 15++?

Posted by Marvyn Choong > 2014-11-20 10:06 | Report Abuse

I think DKSH easily worth more than PE 20.
At PE 20, DKSH will be RM10.

Posted by Marvyn Choong > 2014-11-25 18:46 | Report Abuse

Why bother when Mr Market offers you ultra low price for your business? If you are not in need of money urgently, why sell at any price that Mr Market offers?

Posted by Marvyn Choong > 2014-12-04 12:12 | Report Abuse

Haha... The hidden hand is powerful... Salute!

Posted by AnakTimur > 2014-12-16 15:34 | Report Abuse

Liquidity problem...

Posted by Marvyn Choong > 2014-12-16 20:25 | Report Abuse

It will go to RM4.

Posted by Abudance > 2015-01-01 05:05 | Report Abuse

X

Posted by Abudance > 2015-01-01 05:07 | Report Abuse

Too many pharmaceutical companies in competition now ... Pharmaniaga has to make a big provision for huge bad debts from government contracts ..

Posted by HJey > 2015-01-20 21:47 | Report Abuse

You all need to understand more about DKSH business model. There is one major change going to take place in DKSH

Posted by zackyh > 2015-01-21 16:49 | Report Abuse

and whats that?

Posted by chrischan > 2015-01-21 16:56 | Report Abuse

http://klse.i3investor.com/blogs/Patient%20Investors%20Will%20Always/68338.jsp

kikiki!!!!hjey share with us!!!!+20% in a week from ur post!!!!understand u dont want share with sing con!!!!can email me if u want!!!!kikiki!!!

Posted by forsight > 2015-01-22 11:54 | Report Abuse

haha! insider information? the businesses that DKSH supplies to are all experiencing a tremendous slow down... how's that for insider information?

Posted by here > 2015-02-13 13:31 | Report Abuse

DKSH and EnvisionTEC sign first distribution agreement for five countries in Asia

03.02.2015 | DKSH, the leading Market Expansion Services provider with a focus on Asia and the German company EnvisionTEC, have signed a distribution agreement for EnvisionTEC’s 3D printing solutions and rapid prototyping systems for Malaysia, the Philippines, Singapore, Taiwan and Vietnam.

Posted by here > 2015-02-13 13:31 | Report Abuse

Roland Berger Strategy Consultants released its fourth report on the Market Expansion Services industry in Asia and projects a promising annual market growth of 7.4% up to 2019

11.02.2015 | DKSH, the leading Market Expansion Services provider with a focus on Asia, operates in an attractive market with a projected growth of 7.4% per year up to 2019, as confirmed by the most recent market study conducted by Roland Berger Strategy Consultants.

Posted by here > 2015-02-13 14:08 | Report Abuse

DKSH Brands/Trademarks - Morgan http://morgan.my/index.php, BiO-Life http://www.biolife.com.my/v/default/index

Posted by Cheng Kok Pin > 2015-03-24 16:58 | Report Abuse

Company is cash rich after selling away the transport business last year. A final dividend is due. Very high probability of special dividend in view of high cash position.

Posted by Marvyn Choong > 2015-03-27 16:19 | Report Abuse

DKSH rebound? Not touching RM4?

Posted by gnail > 2015-03-29 16:26 | Report Abuse

excellent company with consistent growth, worth investing for long term...

Posted by SmartAss > 2015-04-27 13:32 | Report Abuse

Not consider buying yet at this price......

Posted by hardcoreprince > 2015-06-19 17:19 | Report Abuse

Marvyn Chong I think u know rubbish about stocks... RM4... u sell me ar??? who wan to sell???

Posted by daisidoi > 2015-06-20 20:43 | Report Abuse

have friends working in DKSH PJ. good company.

Posted by daisidoi > 2015-06-20 20:44 | Report Abuse

DKSH to announce half-year results 2015 on Monday, July 13, 2015

http://www.dksh.com/htm/388/en/DKSH-to-announce-half-year-results-2015-on-Monday-July-13-2015.htm?Id=668135

Posted by daisidoi > 2015-06-20 20:45 | Report Abuse

DKSH and AstraZeneca expand relationship in South East Asia

http://www.dksh.com/htm/388/en/DKSH-and-AstraZeneca-expand-relationship-in-South-East-Asia.htm?Id=667159

Posted by Marvyn Choong > 2015-06-23 13:16 | Report Abuse

Hardcoreprince, yes, u are damn correct. I know nuts about stocks, especially DKSH. It is touching RM5 now and testing RM4.90... Please help to buy more to sustain it to prevent it going to RM4....

Posted by leehualoon > 2015-07-09 14:05 | Report Abuse

DKSH, Omron seal deal to extend partnership

http://www.thestar.com.my/Business/Business-News/2015/06/26/DKSH-Omron-seal-deal-to-extend-partnership/?style=biz

Posted by Marvyn Choong > 2015-07-09 16:49 | Report Abuse

RM4.86.... Lao Sai...

Posted by gnail > 2015-07-30 22:01 | Report Abuse

laosai until RM4.75, time to collect

Posted by Marvyn Choong > 2015-07-30 22:41 | Report Abuse

Collect now? Too early.. It will go down some more..

Posted by gnail > 2015-07-31 10:10 | Report Abuse

Marvyn choong, when do you think is the best time to collect? it seems like selling pressure is still a lot

Posted by daisidoi > 2015-08-05 11:11 | Report Abuse

Good bye DKSH, long way to fall.. no patience to play with it. switch counter.

Posted by gnail > 2015-08-05 15:52 | Report Abuse

gg liao, ciao first...

Posted by daisidoi > 2015-08-05 16:18 | Report Abuse

rather cut loss....go other counter. lost patience.

Posted by gnail > 2015-08-06 17:26 | Report Abuse

still dropping

Posted by here > 2015-08-10 10:57 | Report Abuse

DKSH expands in East Malaysia by opening new distribution center

06.08.2015 | DKSH, the leading Market Expansion Services provider with a focus on Asia, aims to capture opportunities in the promising East Malaysian market with the opening of a new distribution center in Kota Kinabalu. The facility opens new doors for consumer goods and healthcare companies seeking to grow their business presence in East Malaysia.

Kota Kinabalu, Malaysia, August 6, 2015 – DKSH, the leading Market Expansion Services provider with a focus on Asia, strengthens its growth platform in Malaysia by expanding its infrastructure through the opening of a 207,000 sqft (19,200 sqm) consumer goods and healthcare distribution center in Kota Kinabalu, Sabah.


The larger and more advanced distribution center replaces an older facility which was operating at full capacity. The distribution center represents a significant capacity upgrade in DKSH Malaysia’s consumer goods and healthcare infrastructure and is part of its growth plans in the Sabah region.


The newly built facility is strategically located in Kota Kinabalu Industrial Park (KKIP) with easy access to Sepanggar Bay Container Port and to the city center. Well connected to the transportation network, it allows DKSH to directly serve about 1,000 of DKSH’s consumer goods and healthcare customers in the region, including modern and traditional retail outlets, hospitals, clinics and pharmacies. The new distribution center also serves as a regional hub for the company’s smaller facilities in Tawau and Sandakan.


Speaking at the opening event, Nicholas McLaren, Head Country Management, DKSH Malaysia, said: “With its solid infrastructure, strategic location and sound logistics services, the new distribution center strengthens DKSH’s unique and vast capillary distribution network in East Malaysia. We are well-positioned to leverage on Sabah’s promising market opportunities and growing demand for fast moving consumer goods, personal care, pharmaceuticals, medical devices and consumer health products.”


“The new distribution center will help us to better cater to our clients and customers, offering them the highest level of operational efficiency in logistics and distribution services, ensuring faster route-to-market and ultimately helping them grow their business in East Malaysia,” he added.


Built for future growth, the distribution center offers an additional capacity of 75,000 sqft (6,900 sqm) for further expansion. The temperature-controlled facility is equipped with a 29,000 sqft (2,700 sqm) cold chain room for the storage and efficient handling of consumer and healthcare products including food categories, pharmaceuticals, vaccines and life-saving medicine. Managed by a state-of-art distribution managing system, it has a capacity of over 3,500 stock-keeping units (SKUs) and is designed to store up to 9,000 pallets.


In line with DKSH’s dedication to quality assurance and compliance, the facility complies with Good Distribution Practices (GDP) and Good Distribution Practices for Medical Device (GDPMD) as well as adheres to stringent ISO 9001:2008 and ISO 13485:2003 international standards.


The new distribution center replaces DKSH’s older facility in Kolombong and strengthens DKSH Malaysia’s capabilities and service offerings along the entire value chain and will contribute to the Group’s reputation as the leading Market Expansion Services provider with a focus on Asia.

Posted by here > 2015-08-10 11:09 | Report Abuse

DKSH (M) drop because of Malaysia currency. DKSH (M) drop started on last year July/August 2014 till now, by looking at the chart it is about the same time when Malaysia Ringgit(USD/MYR chart) currency drop.

1. Malaysia Currency
2. Politics in Malaysia

Posted by Derreck Lim Kar Weng > 2015-08-12 12:36 | Report Abuse

wonder would it drop to RM 4 lol

Posted by Marvyn Choong > 2015-08-17 17:46 | Report Abuse

Gnail.. Wait... Not so soon. I think still can go lower...

Posted by Marvyn Choong > 2015-08-17 17:48 | Report Abuse

Hardcoreprince, where are u? RM4 is very near now... Faster buy more lah...

Posted by gnail > 2015-08-26 08:49 | Report Abuse

RM3 is coming

Posted by okdoke > 2015-08-26 16:27 | Report Abuse

Marvyn, what would be a good price to enter? thanks in advance

Posted by gnail > 2015-08-27 13:27 | Report Abuse

the moment when najib turun, then you can enter, haha

Posted by Marvyn Choong > 2015-09-14 17:05 | Report Abuse

First of all, I do not believe Najib will step down anytime within the next 6 months to 1 year. And secondly, this share very illiquid. It will go down to RM3. Fingers crossed.

Posted by gnail > 2015-09-15 17:16 | Report Abuse

hailat, RM3.55 only now

Posted by gnail > 2015-09-18 15:59 | Report Abuse

rebounced!

Posted by Marvyn Choong > 2015-09-18 20:23 | Report Abuse

Rebounced because of Najib lor.. http://mobile.reuters.com/article/idUSK7N0V700L20150914